Story thread · 4 reports / 3 sources
Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto
cryptobriefing.com · 12d
How the coverage leans
Across 3 sources · syndicated copies counted once
Andreessen Horowitz's biotech investment signals a strategic shift, highlighting evolving VC priorities and potential sectoral realignments. The post Braveheart Bio seeks $319M in IPO backed by a16z, signaling VC firm’s expanding appetite beyond crypto appeared first on Crypto Briefing .
First report: A16z-Backed Biotech Braveheart Seeks $318.8 Million in US IPO — bloomberg.com, 12d
The coverage
- Braveheart Bio targets $1.2 billion valuation in US IPO
investing.com · 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.